$NBIS

With a $40 Billion Backlog, Nebius Stock Appears Positioned for Sustained Growth

Nebius reported Q4 FY25 revenue up 547% YoY and guided Q1 FY26 revenue growth of 684%. For FY26, it expects revenue of $3.0B to $3.4B and ARR of $7B to $9B, with adjusted EBITDA guidance of 40%. The company said it ended Q1 with $9.3B cash and has $40B contracted revenue from customers including Microsoft and Meta. Analysts rate NBIS “Moderate Buy” with a $252.07 mean target.

Original reporting
Published Aug 12, 2026, 4:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 4:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
With a $40 Billion Backlog, Nebius Stock Appears Positioned for Sustained Growth — source image
Decision brief

The 30-second read

$NBISBullishMed
01

Why it matters

Traders can use the FY26 revenue, ARR, and adjusted EBITDA guidance plus the $40B contracted backlog to update forward estimates and risk assumptions around credit and execution.

02

Market read

Forward guidance and backlog visibility are the main tradable inputs, supporting a growth-credit narrative.

03

What to watch

Contracted revenue backlog concentration (named large customers) raises customer concentration and renewal risk if spending priorities shift.

Relevance 7/10Novelty 6/10Timing: pre-market today

Background

The piece frames Nebius as a high-growth AI infrastructure provider with strong operating profitability and secured financing.

Company-level read

Ticker impact

$NBISBullishMedium confidence
Context

Nebius guided FY26 revenue $3B-$3.4B and ARR $7B-$9B, with adjusted EBITDA guidance of 40% and a $40B contracted revenue backlog.

Expected impact

Near-term upside bias as traders price in the FY26 revenue/ARR and backlog visibility; volatility likely if margins or cash burn diverge.

Evidence & confidence

The article provides specific forward guidance (revenue, ARR, adjusted EBITDA) plus a large contracted backlog and cash buffer, which are direct inputs to valuation and credit risk.

Market effects

Highlights demand visibility and financing strength in the AI/data infrastructure space, potentially supporting sentiment for similarly positioned growth names.

No clear regional-specific impact stated.

Backlog includes large US tech customers, which can reinforce global AI infrastructure spending expectations.

Counterpoint

The article’s growth rates are extremely high, so investors may discount the sustainability of ARR conversion, margin expansion, or cash flow timing.

Key entities

  • Nebius

    Subject of the article, with FY26 guidance and a $40B contracted revenue backlog cited.

  • Microsoft

    Named as a customer contributing to the $40B contracted revenue backlog.

  • Meta

    Named as a customer contributing to the $40B contracted revenue backlog.

Related articles

$NBISMedAI 8/10

CoreWeave’s Record Q2 Supercharges Nebius Stock Ahead Of Earnings — What Does Wall Street Expect Amid Cloud Boom?

CoreWeave reported record Q2 results, with revenue up 112% to $2.58B and adjusted loss per share of $1.03, beating estimates, and raised 2026 guidance to $12.4B-$13.2B revenue and $35B-$39B capex. Nebius (NBIS) shares rose about 7% ahead of its Q2 report, with analysts expecting revenue up 446% to $574.6M and a $0.70 adjusted loss per share.

$NBISMed

Nebius Group NBIS Rallies As $1B AI Deal Fuels Volatility

Nebius Group N.V. (NBIS) rose in premarket after announcing a multi-year deal to sell more than $1B of computing power to Reflection AI through 2029, according to the report. The article cites NBIS as an AI-cloud data center operator and notes volatility tied to AI infrastructure and New York hyperscale moratorium news.

$CRWVHighAI 8/10

After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB

After-hours trading saw gains in CoreWeave (CRWV) after a smaller-than-expected Q2 loss of $1.14 per share on $2.58B revenue and a $104B backlog plus $25B+ Q3 commitments. Super Micro (SMCI) rose on Q4 results and Q1 FY2027 revenue guidance $14.5B-$15.5B. CAVA, LITE, and HRB also moved on quarterly beats and outlooks.

$NBISMed

Nebius Is Rising While Oracle Falls: NVIDIA’s Massive $500 Billion Funding Plan Pushes the Stocks in Opposite Directions

Nebius Group (NBIS) rose about 3.7% to around $191 midday Tuesday while Oracle (ORCL) fell about 3.9% to about $145. The move followed reports that NVIDIA (NVDA) is pushing a roughly $500 billion “neocloud” AI infrastructure funding plan, including a $2 billion pre-funded warrant for Nebius. Nebius reported Q2 AI Cloud segment growth of 841% and has an average analyst price target near $250.75.

$NBISMed

DA Davidson cuts Nebius target 30% as Vineland delays threaten 2026 guidance

DA Davidson cut its Nebius Group (NBIS) price target to $175 from $250 and kept a Neutral rating, citing construction delays at Nebius’ Vineland, New Jersey data-center project. The firm said Vineland may not be completed in 2026, potentially weakening Nebius’ 2026 guidance. Nebius previously said it was on track to deliver capacity to Microsoft.

$NBISMed

Why is Nebius stock rallying today?

Nebius Group NV shares rose about 5.4% to $194.06 after Goldman Sachs issued a bullish pre-earnings note ahead of Q2 2026 results, citing strong AI infrastructure demand, sold-out Q1 capacity, and an asset-light model. CoreWeave is also set to report. DA Davidson cut its target to $175 from $250. Nebius Q1 revenue rose 684% YoY; FY guidance is $3.0B to $3.4B.